| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.09 | 0.1 |